Skip to main content

Joseph Gilliam

Equibles does not estimate personal net worth.

Get an email with a short summary when 10x Genomics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TXG alerts

About Joseph Gilliam

Joseph Gilliam is recorded as Board Member at 10x Genomics, Inc. (TXG) since October 28, 2026. 10x Genomics, Inc. reported in an 8-K filed November 2, 2026 that Joseph Gilliam was appointed Class III director, effective October 28, 2026. 10x Genomics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at 10x Genomics, Inc. includes Serge Saxonov (CEO and Board Member), John R. Stuelpnagel (Chairman and Board Member), Mr. Gilliam (Chairman) and 7 others.

“On October 28, 2026, upon the recommendation of its Nominating and Corporate Governance Committee, the Board of Directors of 10x Genomics, Inc. (the “Company”) appointed Ansuman Satpathy and Joseph Gilliam to the Board of Directors as Class III directors effective immediately, each with a term expiring at the Company's 2028 annual meeting of stockholders or until his successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal.”
10x Genomics, Inc. Form 8-K, filed November 2, 2026 · Read the filing

Affiliation history

Company network

Current role

Medical Devices · Healthcare

Board Member

2026-10-28–present

Leadership on record at 10x Genomics, Inc.

Recent activity